Piramal Pharma secures Approval to Launch Neoatricon in the UK

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Naeoatricon for use by Piramal Critical Care (PCC) and Ireland-based BrePco Biopharma Ltd (BPCO), according to a statement from Piramal Pharma Limited. It is the first....

Breakthrough MRI Technology Enables Life-Changing Epilepsy Surgery

A new approach has made it possible for ultra-powerful 7T MRI scanners to reveal fine brain differences responsible for therapy-resistant epilepsy...

Bill Gates, Jitendra Singh Explore Biotech and Health Innovations in India

The meeting, which was announced on Thursday by the Ministry of Science & Technology, was attended by Union Minister...

Karnataka Govt Promotes KWIN City as Investment Hub for Medical Aesthetics

Karnataka is becoming an important hub for investments in the fields of dermatology and cosmetic medical treatments, as the state government emphasizes prospects in the forthcoming KWIN City initiative. The Minister of Large and Medium Industries, M

Bharat Biotech Introduces India's First Integrated Cell & Gene Therapy

Bharat Biotech International Limited (BBIL) has expanded its expertise from vaccine innovation to cutting-edge regenerative and personalized therapies that offer hope to millions of people by establishing India's only vertically integrated...

India's specialty chemicals recover as pharma exports continue strong growth

India's specialty chemicals industry is bouncing back in Q4 FY25, while pharma exports continue to grow at 8-9% backed by sustained demand for...

CAR-T therapy to transform cancer treatment in India

As society grows in knowledge and confidence regarding an available policy, training, and infrastructure, CAR-T cell therapy will shake up...

Eli Lilly launches Mounjaro in India for obesity & diabetes management

Eli Lilly and Company has launched Mounjaro in a single-dose vial, which has been authorized to be marketed by the Central Drugs Standard Control Organization (CDSCO). This first-ever treatment drug...

AIMED Calls for Reassessment of Medical Device Import Duties

The central government has been urged to reconsider discussions about reducing import taxes on medical devices from the United States by the Association of Indian Medical Device Industry (AIMED). According to the industry organization, these changes

Tech Mahindra, NVIDIA Partner for AI-Powered Drug Safety Innovation

In a tactical initiative to improve drug safety oversight, Tech Mahindra, a worldwide frontrunner in technology consulting and digital services, has revealed an AI-based pharmacovigilance (PV) solution utilizing NVIDIA AI software. The solution seeks

© 2025 India Pharma Outlook. All Rights Reserved.